Induction of a local pseudo-pregnancy via levonorgestrel-loaded microspheres for the treatment of endometriosis in a rabbit model
article
OA: bronze
CC0
⤵ 10 in-corpus citations
Abstract
BACKGROUND: Endometriosis is a chronic disease that responds to systemic pseudo-pregnancy therapy. However, side effects limit their long-term use, and recurrence often occurs after cessation of medication. Reducing side effects whereas improving therapeutic efficacy of pseudo-pregnancy therapy seems contradictory, but appealing. In order to address this dilemma, the efficacy and side effects of local pseudo-pregnancy therapy were investigated for the first time in an endometriosis animal model. METHODS AND RESULTS: Levonorgestrel-loaded polylactic acid microspheres (LNG-microspheres) were prepared by using an oil-in-water emulsification-solvent evaporation method. Rabbits with experimental endometriosis were randomized to treatment with local pseudo-pregnancy therapy, local blank microspheres, systemic pseudo-pregnancy therapy, ovariectomy or the control. Local pseudo-pregnancy was induced by injection of LNG-microspheres directly into endometrial cysts. Compared with the systemic pseudo-pregnancy group, significantly higher intra-cystic drug levels were maintained for at least 6 months with much lower serum levels in the local pseudo-pregnancy group (P < 0.01). The high intra-cystic levonorgestrel simulated a state of potent pregnancy, which induced size reductions and endometrial atrophy comparable to those of ovariectomy. Moreover, major metabolic parameters and ovarian function were not disturbed by local pseudo-pregnancy therapy. CONCLUSIONS: Induction of a local pseudo-pregnancy could achieve therapeutic efficacy comparable to that of ovariectomy without provoking any marked side effects in a rabbit endometriosis model. Thus it may be a preferable option for patients with endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (31)
- A retrospective analysis of ovarian endometriosis during pregnancy via openalex
- Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study via openalex
- Effect of endometriosis on ovulation, ovum pickup, fertilization and tubal transport in the rabbit via openalex
- Endometriosis with intestinal perforation in term pregnancy via openalex
- Intrapelvic injection of menstrual endometrium causes endometriosis in baboons (Papio cynocephalus and Papio anubis) via openalex
- Is There a Role for Use of Levonorgestrel Intrauterine System in Women with Chronic Pelvic Pain? via openalex
- Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex
- Management of ovarian endometriomas via openalex
- PERFORATION OF THE SIGMOID COLON DURING PREGNANCY: A RARE COMPLICATION OF ENDOMETRIOSIS via openalex
- Pharmacological profile of progestins via openalex
- Progestogens for endometriosis: forward to the past via openalex
- Randomized clinical trial of two laparoscopic treatments of endometriomas: cystectomy versus drainage and coagulation via openalex
- Recognizing endometriosis as a social disease: the European Union-encouraged Italian Senate approach via openalex
- SURGICAL TREATMENT OF ENDOMETRIOSIS via openalex
- Symptomatic large bowel endometriosis in a woman with a hormonal intrauterine device: a case report. via openalex
- The evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease via openalex
- TISSUE CONCENTRATIONS OF LEVONORGESTREL IN WOMEN USING A LEVONORGESTREL‐RELEASING IUD via openalex
- Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex
- W4200472726 via openalex
- W1756838878 via openalex
- W2003742048 via openalex
- W2011872290 via openalex
- W2019232995 via openalex
- W2045931316 via openalex
- W2053419263 via openalex
- W2070761958 via openalex
- W2103414676 via openalex
- W2105852378 via openalex
- W2119767373 via openalex
- W2146841362 via openalex
- W2323719507 via openalex
Cited by (10)
- Endometrial diseases: a summary of small experimental animal model† 2025
- WITHDRAWN: Endometriosis related sex steroid hormones, hypothalamic pituitary gonadal axis hormones and related animal modeling: A comprehensive review of published articles and endometriosis induction methods from 2010 to 2021 with scoring based approach 2021
- Drug delivery for the treatment of endometriosis and uterine fibroids 2017
- Evaluation of peritoneal endometriosis treatment using intralesional acetylsalicylic acid injection in rabbits 2016
- Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis 2014
- Apoptosis in Endometriosis 2014
- Endometriosis in Experimental Models 2014
- Long-term regression of experimental endometriosis in a rat model treated with local application of levonorgestrel-loaded biodegradable microspheres 2012
- Surgical Management Options for Patients with Infertility and Endometriosis 2010
- Apoptosis and endometriosis 2010
Source provenance
- europepmc
- last seen: 2026-06-19T06:14:56.452680+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:53.633898+00:00
License: CC0
· commercial use OK